N-Allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide

Catalog No. :
ACFVFU003
CAS No. :
133886-40-5
Molecular Formula :
C13H15NO2S
Molecular Weight :
249.34

IUPAC Name:N-allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide

N-Allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$101.00Login to see priceIn stockInquiry
250mg97%$181.00Login to see priceIn stockInquiry
1g97%$488.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide
IUPAC NameN-allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide
MDL No.MFCD06200245
Molecular FormulaC13H15NO2S
Molecular Weight249.34
SMILESO=S(C1=CC=C(C)C=C1)(N(CC=C)CC#C)=O
InChI KeyQITLNHICIUWDTD-UHFFFAOYSA-N
SynonymBenzenesulfonamide, 4-methyl-N-2-propenyl-N-2-propynyl-;Benzenesulfonamide, 4-methyl-N-2-propen-1-yl-N-2-propyn-1-yl-;N-Allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide
CAS No.133886-40-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACFVFU003 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFVFU003 route product structure diagram
    ACFVFU003133886-40-5 In Stock
Inquiry

2. ACFVFU003 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTIDQ016 route compound structure diagram
    ACTIDQ01650487-71-3 In Stock
  4. Then
  5. ACFVFU003 route product structure diagram
    ACFVFU003133886-40-5 In Stock
Inquiry

Comments (0)